|
ATM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.43720052420338E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.96479998726807E-09 |
| Normal-vs-Stage2 |
2.87250223607316E-11 |
| Normal-vs-Stage3 |
3.33529870388816E-11 |
| Normal-vs-Stage4 |
2.00520045012809E-10 |
| Stage1-vs-Stage2 |
1.665980E-02 |
| Stage1-vs-Stage3 |
1.183530E-02 |
| Stage1-vs-Stage4 |
6.336400E-02 |
| Stage2-vs-Stage3 |
6.016600E-01 |
| Stage2-vs-Stage4 |
6.034600E-01 |
| Stage3-vs-Stage4 |
9.623200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.02569985627588E-10 |
| Normal-vs-AfricanAmerican |
5.96190000035079E-07 |
| Normal-vs-Asian |
1.69260000015825E-07 |
| Caucasian-vs-AfricanAmerican |
7.532000E-01 |
| Caucasian-vs-Asian |
3.059200E-01 |
| AfricanAmerican-vs-Asian |
6.711600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.32940383332925E-11 |
| Normal-vs-Female |
8.57980020363414E-10 |
| Male-vs-Female |
1.560400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.42150000051566E-08 |
| Normal-vs-Age(41-60Yrs) |
1.90449989112551E-10 |
| Normal-vs-Age(61-80Yrs) |
1.7123968909516E-11 |
| Normal-vs-Age(81-100Yrs) |
1.282800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.190100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.299000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.746200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.919200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.318000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.917800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.061770E-01 |
| Classical-VS-Follicular |
5.423100E-03 |
| Classical-VS-Other |
3.916400E-01 |
| Classical-VS-Normal |
1.07469999566234E-08 |
| Tall-VS-Follicular |
8.647000E-01 |
| Tall-VS-Other |
9.844400E-01 |
| Tall-VS-Normal |
7.96650001522181E-09 |
| Follicular-VS-Other |
9.414400E-01 |
| Follicular-VS-Normal |
7.20330461945196E-11 |
| Other-VS-Normal |
3.579400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.97319987810852E-11 |
| Normal-vs-N1 |
1.25249999261001E-09 |
| N0-vs-N1 |
7.027200E-01 |
|
|
